Zoetis | ZTS - Assets




Zoetis reported $14.24B in Assets for its fiscal quarter ending in December of 2024.

Assets Change Date
AbbVie USD 143.42B 1.48B Sep/2024
Align Technology USD 6.21B 151.37M Dec/2024
Bayer EUR 106.95B 12.91B Sep/2024
Bristol-Myers Squibb USD 92.6B 1.07B Dec/2024
Charles River Laboratories USD 7.53B 475.5M Dec/2024
Dentsply International USD 6.63B 271M Sep/2024
Eli Lilly USD 75.61B 3.73B Sep/2024
Henry Schein USD 10.6B 354M Sep/2024
Idexx Laboratories USD 3.29B 57.32M Dec/2024
Illumina USD 6.3B 289M Dec/2024
IQVIA Holdings USD 26.9B 281M Dec/2024
J&J USD 178.29B 2.8B Sep/2024
Laboratory Of America USD 18.38B 233.5M Dec/2024
Merck USD 117.53B 4.9B Sep/2024
Neogen USD 4.05B 449.08M Nov/2024
Pacira USD 1.52B 125.13M Sep/2024
Patterson Companies USD 2.85B 0 Oct/2024
Perrigo USD 11.2B 805.9M Sep/2024
Pfizer USD 219.48B 3.28B Sep/2024
Quest Diagnostics USD 16.15B 58M Dec/2024
Sanofi 129.76B 3.29B Jun/2024
Sanofi 129.76B 3.29B Jun/2024
Zoetis USD 14.24B 120M Dec/2024